|
|||||
A drug based on chemicals derived from cannabis plants was approved by Food and Drug Administration for marketing in the U.S. to treat seizures associated with two rare and severe forms of epilepsy. . . . → Read More: Cannabis Drug Approved by FDA for Rare, Severe Seizures  Comments are closed  Regulations  biomedical, clinical trials, Europe, FDA, life sciences, pharmaceuticals, U.K. 
A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO Comments are closed Finance biomedical, cancer, clinical trials, entrepreneurs, equity, Europe, investment, IPO, life sciences, pharmaceuticals, U.K., university 
An engineering team produced with an ink-jet printer working electrodes like those used in medical implants on bio-friendly soft materials rather than metal or silicon. . . . → Read More: Electrodes for Implants 3-D Printed on Soft Materials 2 comments - (Comments are closed) New products biomedical, engineering, Europe, life sciences, materials science, medical device, physical sciences, semiconductors, university 
A company that applies genetic engineering to limit the spread of disease-carrying pests is partnering with the Bill and Melinda Gates Foundation to develop mosquitoes that stop the spread of malaria. . . . → Read More: Gates Backs Engineered Mosquitoes to Stop Malaria One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Europe, genomics, life sciences, U.K. 
University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent Comments are closed Intellectual property biomedical, biotechnology, Europe, genomics, life sciences, patent, university, USPTO 
A new initiative in Europe is investigating the connection between a person’s molecular composition and autism, particularly when other disorders complicate that individual’s condition. . . . → Read More: 115M Euro Grant for Precision Medicine, Trials in Autism One comment - (Comments are closed) Finance biomedical, clinical trials, Europe, grant, life sciences, pharmaceuticals, U.K., university 
Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals 
A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care One comment - (Comments are closed) New products biomedical, cancer, engineering, Europe, genomics, life sciences, mathematics, medical device, NIH, pharmaceuticals, physical sciences, software 
The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases One comment - (Comments are closed) Regulations biomedical, biotechnology, clinical trials, Europe, FDA, genomics, licensing, life sciences, pharmaceuticals, stem cells 
A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns. . . . → Read More: New ALS Drug Formula Shown Active, Safe Comments are closed New products biomedical, biotechnology, clinical trials, entrepreneurs, Europe, FDA, life sciences, pharmaceuticals |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
